Market Cap (In CNY)
3.73 Billion
Revenue (In CNY)
411.32 Million
Net Income (In CNY)
-76.06 Million
Avg. Volume
5.07 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.58-17.4
- PE
- -
- EPS
- -
- Beta Value
- 0.433
- ISIN
- CNE1000041S6
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jie Zhang
- Employee Count
- -
- Website
- https://www.aidea.com.cn
- Ipo Date
- 2020-07-20
- Details
- Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefradine capsules, as well as raw materials. The company was founded in 2009 and is based in Yangzhou, China.
More Stocks
-
CONARTConart Engineers Limited
CONART
-
GAU
-
SU
-
FSRCYFirst Resources Limited
FSRCY
-
4160
-
SGY
-
TROYTroy Minerals Inc.
TROY
-
002347